Konstantinos Syrigos to Follow-Up Studies
This is a "connection" page, showing publications Konstantinos Syrigos has written about Follow-Up Studies.
Connection Strength
0.030
-
Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations. J Thorac Oncol. 2018 12; 13(12):1884-1896.
Score: 0.012
-
Lapatinib with whole brain radiotherapy in patients with brain metastases from breast and non-small cell lung cancer: a phase II study of the Hellenic Cooperative Oncology Group (HeCOG). J Neurooncol. 2017 Sep; 134(2):443-451.
Score: 0.011
-
High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma. Clin Cancer Res. 2009 Jun 15; 15(12):4157-64.
Score: 0.006